Sphera Funds Management Ltd. Homology Medicines, Inc. Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$9.94 - $16.59 $6.55 Million - $10.9 Million	-658,919 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$12.07 - $19.34 $6.01 Million - $9.63 Million	497,919 Added 309.27%	658,919 $10 Million
Q4 2018 Feb 14, 2019	SELL	$18.39 - $26.3 $1.55 Million - $2.21 Million	-84,104 Reduced 34.31%	161,000 $3.6 Million
Q3 2018 Nov 14, 2018	BUY	$15.54 - $22.86 $1.6 Million - $2.36 Million	103,268 Added 72.81%	245,104 $5.6 Million
Q2 2018 Aug 13, 2018	BUY	$16.49 - $21.55 $145,705 - $190,415	8,836 Added 6.64%	141,836 $2.89 Million

Q1 2018 May 10, 2018	BUY	$18.66 - $18.7 $2.48 Million - $2.49 Million	133,000 New	133,000 $2.49 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.